Skip to main content
. 2022 Nov 7;10(12):890–900. doi: 10.1016/S2213-8587(22)00278-9

Figure 2.

Figure 2

A strategy for prioritising recall for diabetes review, based on identifiable clinical need

3-monthly reviews of high-risk populations is advocated to prevent adverse outcomes. eGFR=estimated glomerular filtration rate. NA=not applicable.